Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Eur Rev Med Pharmacol Sci ; 26(15): 5485-5488, 2022 08.
Article in English | MEDLINE | ID: mdl-35993644

ABSTRACT

OBJECTIVE: Coagulation parameters are used to diagnose hematological diseases. The correlation between the coagulation parameters and Apgar score at 5 min is yet to be elucidated. The present study aimed at describing the neonatal coagulation parameters in preterm infants with a low Apgar score at 5 min. PATIENTS AND METHODS: In this case-control study, 32 serious preterm infants were compared with 20 preterm infants, according to the Apgar score at 5 min. The prothrombin time (PT), thrombin time (TT), fibrinogen (Fbg), activated partial thromboplastin time (APTT), calculated international normalized ratio (INR), D-dimer (D2), fructose diphosphate sodium (FDP), and procalcitonin (PCT) values were recorded. The linear correlation between coagulation parameters and Apgar score at 5 min was analyzed by linear regression. The two groups were compared using GraphPad Prism 8 (LaJolla, CA, USA). RESULTS: In the study, the mean coagulation parameters were significantly higher in the serious preterm infants with low the Apgar score at 5 min compared to the preterm infants with normal Agar scores at 5 min (p<0.05). The correlation between coagulation parameters and Apgar score at 5 min was recorded (PT: R=0.3984; APTT: R=0.3165; INR: R=0.4139). CONCLUSIONS: The coagulation parameters were significantly higher in serious preterm infants with a low Apgar score at 5 min. Also, the coagulation parameters and Apgar score at 5 min are associated with severity in preterm infants.


Subject(s)
Blood Coagulation , Infant, Premature , Apgar Score , Case-Control Studies , Humans , Infant , Infant, Newborn , Partial Thromboplastin Time
2.
Acta Virol ; 58(4): 368-73, 2014.
Article in English | MEDLINE | ID: mdl-25518720

ABSTRACT

Herpes simplex virus 1 (HSV-1) is one of the most prevalent human pathogens in both industrialized and developing countries. This study was performed to analyze the antiviral activity of purified flavonoid from Polygonum perfoliatum L. against HSV-1 infection in vitro and in vivo. Flavonoid showed no inhibitory effect, when treated before virus infection, but it strongly inhibited viral replication and cell-to-cell spread which was vital for the virus's propagation. The therapeutic effect of the flavonoid in treating HSV-1 induced encephalitis was also investigated in mice. A dose-dependent increase of survival rate and mean survival time (MST) were observed in the flavonoid-treated mice. These results suggested that the flavonoid may be a viable therapeutic option for recurrent HSV-1 infection.


Subject(s)
Antiviral Agents/pharmacology , Flavonoids/pharmacology , Herpes Simplex/drug therapy , Herpesvirus 1, Human/drug effects , Plant Extracts/pharmacology , Polygonum/chemistry , Animals , Antiviral Agents/analysis , Flavonoids/analysis , Herpes Simplex/virology , Herpesvirus 1, Human/physiology , Humans , Mice , Plant Extracts/analysis , Virus Replication/drug effects
3.
Intervirology ; 56(3): 172-7, 2013.
Article in English | MEDLINE | ID: mdl-23306793

ABSTRACT

OBJECTIVE: Hantaan virus (HTNV) is one of the main etiologic agents for hemorrhagic fever with renal syndrome in China. However, it is very difficult to isolate the virus from its original host, which hampers the viral characterization. This study describes an efficient method for isolating HTNV in suckling mice. METHODS: Hantavirus-infected Apodemus agrarius were screened by quantitative real-time PCR. The homogenates of one positive rodent lung tissue were inoculated into suckling mice for virus propagation through serial passages. RESULTS: During the three passages in suckling mice, the number of viral RNA copies/nanogram of GAPDH mRNA increased significantly ranging from 477 to 7,278 and 46 to 4,898 in the tissues of brain and lung, respectively. Hantaviral antigens could be detected by indirect immunofluorescence assay and around 100-nm virion-like structures were also observed in brain tissue by transmission electron microscopy. No nucleotide exchange was found except for one in the 3'-non-coding domain of S segment when comparing the complete genome sequences from hantavirus in the first and the third passages. CONCLUSION: These results suggest inoculation of suckling mice with suspected hantavirus-infected rodent samples is an efficient method for isolation and maintenance of HTNV.


Subject(s)
Hantaan virus/isolation & purification , Virology/methods , Animals , Animals, Newborn , Hantaan virus/genetics , Hantaan virus/ultrastructure , Mice , Mice, Inbred BALB C , Microscopy, Electron, Transmission , Murinae/virology , RNA, Viral/genetics , Real-Time Polymerase Chain Reaction , Serial Passage/methods , Virion/ultrastructure
4.
Eur J Clin Microbiol Infect Dis ; 30(5): 645-51, 2011 May.
Article in English | MEDLINE | ID: mdl-21222012

ABSTRACT

Hemorrhagic fever with renal syndrome (HFRS) is endemic in East Asia and Europe. This study was initiated to investigate the reactivity of antibodies in sera of Chinese HFRS patients with the recombinant nucleocapsid proteins (rNPs) of Hantaan virus (HTNV), Dobrava-Belgrade virus (DOBV), and Puumala virus (PUUV), which are the prevalent hantavirus strains in Europe. Forty-eight pairs of acute and convalescent sera were collected from HFRS patients in Hubei, China (1985-2002) and tested by indirect IgG, IgA, and IgM enzyme-linked immunosorbent assays with six rNPs of European hantaviruses as coated antigens, respectively. The results showed that the sensitivity of rNPs against IgG was HTNV-rNP > DOBV-rNP > PUUV-rNP, while the sensitivity against IgA was DOBV-rNP > HTNV-rNP > PUUV-rNP. Quantitative analysis revealed both acute and convalescent sera from HFRS patients predominantly exhibit high levels of IgA. Although PUUV-rNPs showed very weak reactivity to the three kinds of immunoglobulins in all samples, three pairs of sera unexpectedly cross-reacted strongly to all three PUUV-rNP subtypes. We first observe that HFRS patients' sera from Hubei Province show new prevalent characteristics of cross-reacting with PUUV-rNPs and continued high level of IgA in convalescent phase, as well as in China.


Subject(s)
Antibodies, Viral/blood , Hantaan virus/immunology , Hemorrhagic Fever with Renal Syndrome/epidemiology , Hemorrhagic Fever with Renal Syndrome/immunology , Orthohantavirus/immunology , Puumala virus/immunology , Adolescent , Adult , Aged , Aged, 80 and over , Capsid Proteins/immunology , China/epidemiology , Humans , Immunoglobulin A/blood , Immunoglobulin G/blood , Immunoglobulin M/blood , Middle Aged , Nucleocapsid Proteins/immunology , Recombinant Proteins/immunology , Seroepidemiologic Studies , Viral Core Proteins/immunology , Young Adult
5.
Drug Deliv ; 17(1): 28-37, 2010 Jan.
Article in English | MEDLINE | ID: mdl-22747073

ABSTRACT

The study described the development of lipid vesicles as colloidal carriers for uricase, an enzyme with low activity at physicological conditions and low stability in vitro and in vivo. The lipid vesicles containing uricase (UOXLVs) were prepared and the process parameters were optimized with the indexes of entrapment efficiency, polydispersion, particle size, and zeta potential. The storage stability of uricase in lipid vesicles was significantly increased compared to that of free uricase at 4°C. The stability to proteolytic digestion was also increased obviously by entrapping the uricase in the lipid vesicles. In vitro and in vivo pharmacodynamic studies on the hyperuricemia rat model explicitly suggested that the uricase entrapped by UOXLVs possessed high uricolytic activity and distinctively decreased the uric acid level.


Subject(s)
Drug Carriers/chemistry , Phosphatidylcholines/chemistry , Urate Oxidase/administration & dosage , Animals , Drug Compounding , Drug Storage , Enzyme Stability , Male , Particle Size , Rats , Rats, Sprague-Dawley , Surface Properties , Urate Oxidase/chemistry , Urate Oxidase/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...